Company Intelligence

Due diligence intelligence for active companies. Signal-scored across geopolitical exposure, regulatory risk, and sector tailwinds — ranked by composite risk/opportunity score.

Filters:🇫🇷 France ✕

All energy technology financials healthcare industrials consumer materials utilities defense semiconductors mining pharma telecom shipping agriculture real_estate

All postures ✦ Opportunities ⚠ Risks

Themes for pharma

💊Pharma Supply Chain Reshoring

Total Tracked

Opportunities

Risk Flags

SNY +22

Top Score

✦

Opportunities

(1)

Ticker

Company

Sector

Action

Flag

Score

SNY

🇫🇷Sanofi

Sanofi captures the majority economics of Dupixent post-2025

Sanofi captures the majority economics of Dupixent post-2025 cost-sharing reset with Regeneron, prov

Sanofi captures the majority economics of Dupixent post-2025 cost-sharing reset with Regeneron, providing structural earnings growth. Beyfor

pharma

EARLY

🇫🇷

+22